Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Acknowledgments The authors gratefully acknowledge the Centre for Diabetes, School of Biomedical Sciences, Ulster University (UK)
Marenich, A
This counterintuitive pharmacology has been confirmed in vivo whereby the administration of the FXR agonist GW4064 by mouth drives hyperglycaemia and obesity (349) while intraperitoneal injection exerts protection from it (350)
Miao, L
La duracin ideal del tratamiento, las estrategias para suspender o mantener a largo plazo, y la sostenibilidad del acceso econmico representan desafos cruciales en salud pblica
However, the absence of human clinical trials means the relevance and safety of these mechanisms in humans remains unestablished
